Coherus BioSciences: Q4 Earnings Snapshot
In this article:
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Wednesday reported a loss of $79.7 million in its fourth quarter.
The Redwood City, California-based company said it had a loss of 71 cents per share. Losses, adjusted for one-time gains and costs, were 62 cents per share.
The drug developer posted revenue of $91.5 million in the period.
For the year, the company reported a loss of $237.9 million, or $2.53 per share. Revenue was reported as $257.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
